EFG-Hermes Brokerage on Sunday decreased the price target for Saudi healthcare company Dr. Soliman Abdul Kader Fakeeh Hospital Co. (SASE:4017), d/b/a Fakeeh Care, to 40.00 Saudi riyals from 45.00 riyals, while keeping its neutral rating.
What else is happening in Research?
Research
Goldman Sachs Downgrades Signify to Neutral
Goldman Sachs on Friday downgraded Dutch lighting company Signify (LIGHT.AS) to neutral from buy, while maintaining its price target at 21 euros.
$LIGHT.AS
Research
Citi Upgrades Halma to Buy Rating, Boosts PT
Citi on Friday raised life-saving technology group Halma (HLMA.L) to buy from neutral and increased its price target to 46 pounds sterling from 37 pounds.
$HLMA.L
Research
Riyad Capital Reduces Al-Dawaa Medical Services' PT, Keeps at Neutral
Riyad Capital on Thursday decreased the price target for Saudi Arabian medical services company and pharmacy operator Al-Dawaa Medical Services (SASE:4163) to 45 Saudi riyals from 50 riyals and kept its neutral rating.
SASE:4163